SNOWMASS, COLO. – A full decade after a large multicenter study identified non-Hodgkin’s lymphoma as the major cancer risk associated with SLE, it... More »
SNOWMASS, COLO. – The risk of irreversible hydroxychloroquine toxic retinopathy is much greater than previously appreciated, Dr. James T. Rosenbaum ... More »
Rheumatologists should consider the possibility of Chikungunya virus in patients who present with new symmetric polyarthritis, especially if they have... More »
After a 5-year monopoly on the sale of colchicine put the gout medication out of reach for many patients, a federal judge in January denied an injunct... More »
The risk for developing diabetes mellitus among patients with systemic lupus erythematosus declined significantly with increasing use of hydroxychloro... More »
Two years of either triple therapy or treatment with tumor necrosis factor plus methotrexate failed to eliminate joint inflammation on MRI in a subcoh... More »
Ustekinumab treatment was associated with new-onset or worsening psoriatic arthritis in a series of seven patients with psoriasis.
The findings, which support previous observations that patients...
Ustekinumab treatment was associated with new-onset or worsening psoriatic arthritis in a series of seven patients with psoriasis.
The findings, which support previous observations that patients...
Asian and Hispanic patients with systemic lupus erythematosus have lower all-cause mortality rates than white, black, and Native American patients, ac... More »
Patients with poor-prognosis early rheumatoid arthritis who have been on a regimen of abatacept for at least 1 year and have low disease activity scor... More »